Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Research Article

Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

	Abstract	Full	Pdf
Dec 2019	27	27	0
Jan 2020	9	9	0
Feb 2020	10	10	1
Mar 2020	14	14	1
Apr 2020	6	6	0
May 2020	10	10	2
Jun 2020	12	12	1
Jul 2020	30	30	6
Aug 2020	21	21	0
Sep 2020	16	16	1
Oct 2020	20	20	4
Nov 2020	13	13	4
Dec 2020	7	7	2
Jan 2021	12	12	1
Feb 2021	8	8	2
Mar 2021	10	10	1
Apr 2021	9	9	1
May 2021	2	2	1
Jun 2021	7	7	0
Jul 2021	13	13	1
Aug 2021	0	0	1
Sep 2021	23	23	3
Oct 2021	8	8	2
Nov 2021	12	12	5
Dec 2021	13	13	2
Jan 2022	10	11	2
Feb 2022	9	9	0
Mar 2022	9	9	1
Apr 2022	20	21	3
May 2022	25	25	3
Jun 2022	32	32	4
Jul 2022	15	16	1
Aug 2022	28	28	1
Sep 2022	20	20	14
Oct 2022	15	15	1
Nov 2022	8	53	11
Dec 2022	20	20	0
Jan 2023	9	9	1
Feb 2023	28	28	2
Mar 2023	4	4	0
Apr 2023	2	3	1
May 2023	12	12	3
Jun 2023	3	3	1
Jul 2023	10	10	9
Aug 2023	3	3	3
Sep 2023	7	7	1
Oct 2023	9	9	1
Nov 2023	2	2	0
Dec 2023	16	16	4
Jan 2024	10	11	3
Feb 2024	9	9	2
Mar 2024	3	3	1
Total	650	700	115